Merck kills off new cholesterol-lowering drug I have just come across a very interesting item entitled: “Check the Obits: Lipid Research Died Last Week” (1). It is published by a mainstream medical magazine “Medpage Today”. The...Read More
I have lost count of the number of people I have met who are convinced that they should be concerned about the cholesterol level in their blood. If it is considered to be “too high” then they are at serious risk of suffering...Read More
An essential nutrient? CoQ10 (Ubiquinone) is a coenzyme, which is a vital substance in the body that has many important functions. It plays a key role in the generation of energy in the mitochondria, which are the “powerhouses”...Read More
Background Most people would assume that when a treatment or procedure is recommended that these are based on very sound research, which has demonstrated that they will be effective and that any risks of damage to health will be...Read More
My dear Jeremy, As you know it is imperative that we eliminate the financial deficit and that one key element of our strategy it to ensure that that we use public money as efficiently as possible. Since the election the Treasury...Read More
A comprehensive review on the role of cholesterol in health and a critique of the use of statins has recently been published by a team of Japanese researchers (1). This pulls together information from a range of different...Read More
I have recently been writing letters to our local newspaper “The Craven Herald” (1) in which I have advocated a fundamental shift in NHS policies. My stance is that pouring more and more money into the system is a dead end...Read More
I have just been watching the video entitled “You must be nuts!” which has been made by Obhi Chatterjee and colleagues. It can be viewed on You Tube here: The stimulus for this video was to try to understand why Obhi’s father...Read More
This is a re-post of the article by Francois Lubbe of The Cholesterol Truth. I am most grateful to him for permission to post here. The original is available at Praluent: New Cholesterol Drugs Get Riskier By The Day Big Pharma...Read More
The latest issue of the Health Survey for England provides data on the use of prescribed medicines by people living in the community, which therefore relate to the general population and not just those within the healthcare...Read More
122. Disclosure of the Results of Clinical Trials: Case Study of Tamiflu and Implications for Statins
One of the key issues to emerge from the recent spat between Sir Rory Collins and the BMJ about statins (1) has been the refusal of the Cholesterol Treatments Trialists’ Collaboration (CTT) at Oxford University to allow open...Read More
The banking industry quite rightly suffers from public opprobrium because of its role in the financial crisis, manipulation of the bank rate and mis-selling of various products. By contrast the pharmaceutical industry is...Read More
- 306. Opioids
- 305. A Comparison between the approaches to Type 2 Diabetes (T2D) by Dr David Unwin and Diabetes UK
- 304. Sulphonylureas increase cardiac deaths but are still recommended for use after Metformin in type two diabetics in Scotland.
- 303. Statins: Why it is crucial to have a comprehensive picture
- 302. The Conventional Treatment of Type 2 Diabetes (T2D)
- @pulmo1 "The WHO suspended hydroxychloroquine Solidarity Trials on 25 May. U.S. researchers did the same, as did Ge… https://t.co/uYQM9NOx6T
about 7 hours ago
- So WHO can do whatever it likes and no-one is allowed to question or criticise. Sinister forces at work.
"WHO's ne… https://t.co/NA3tfYjuUm
about 10 hours ago
- BEWARE OF VACCINES!
The swine flu vaccine, developed by GSK is believed to have caused brain damage in 60 patients… https://t.co/aD2wBg3tXR
about 1 day ago
- @sarikaverma84 @BorisJohnson I agree. Unbelievably stupid.
about 2 days ago
- @sarikaverma84 @BorisJohnson Your stance is quite understandable because the government has scared people out of th… https://t.co/NoyHVF57RV
about 2 days ago